Otsuka and Akebia seek USFDA approval for renal anemia drug

Drug Discovery |  News | 0 Comment | 01 Apr, 2022

Otsuka Pharmaceutical has announced that its collaborator Akebia Therapeutics, Inc. (Akebia) has submitted a New Drug Ap...Read more

Insilico Medicine partners with EQRx for AI-driven drug discovery

Drug Discovery |  News | 0 Comment | 25 Mar, 2022

Insilico Medicine, a clinical stage end-to-end artificial intelligence (AI)-driven drug discovery company, has entered i...Read more

Biogen and Eisai amend collaboration agreements on Alzheimer’s disease treatments

Drug Discovery |  News | 0 Comment | 21 Mar, 2022

Biogen Inc. and Eisai Co., Ltd. announced that the companies have amended their existing collaboration agreement on aduc...Read more

RedHill inks deal worth $6M with Kukbo for COVID-19 drug in South Korea

Drug Discovery |  News | 0 Comment | 16 Mar, 2022

RedHill Biopharma has entered into an exclusive license agreement with Kukbo Co., a South Korean corporation, for o...Read more

Astellas’ menopause drug fails in Asia trial

Drug Discovery |  News | 0 Comment | 16 Mar, 2022

Japan-based Astellas Pharma Inc. has announced topline results from the ongoing Phase 3 MOONLIGHT 1 clinical trial inves...Read more

China approves SCG's T Cell Therapy IND to treat Hepatitis B virus

Drug Discovery |  News | 0 Comment | 14 Mar, 2022

Singapore-based SCG Cell Therapy Pte Ltd, a leading biotechnology company,  announced that the China National Medic...Read more

China's Gan & Lee Pharma begins first-in-human trial for diabetes drug

Drug Discovery |  News | 0 Comment | 11 Mar, 2022

Chinese firm Gan & Lee Pharmaceuticals has announced that the first subject has been dosed in our Phase I, double-bl...Read more

Dr Andreas Amrein joins Advanced Clinical to lead global development and expansion in APAC

Drug Discovery |  News | 0 Comment | 10 Mar, 2022

Advanced Clinical, a clinical development and strategic resourcing organization committed to providing a better clinical...Read more

China approves phase II trial of Akeso's cancer drug

Drug Discovery |  News | 0 Comment | 08 Mar, 2022

Akeso, Inc., a biopharmaceutical company dedicated to the development of innovative antibody drugs, has announced that t...Read more

I-Mab receives FDA orphan drug designation for cancer drug

Drug Discovery |  News | 0 Comment | 04 Mar, 2022

China based I-Mab, a clinical-stage biopharmaceutical company committed to the discovery, development, and commercializa...Read more

China-based startup InxMed raises $50 M in Series B Financing

Drug Discovery |  News | 0 Comment | 04 Mar, 2022

InxMed Co., Ltd, a clinical-stage biotechnology startup based in China, has announced that it had completed $5...Read more

China's Adagene partners with French firm Sanofi for Immuno-Oncology

Drug Discovery |  News | 0 Comment | 03 Mar, 2022

China's Adagene,  a company transforming the discovery and development of antibody-based therapies, has announced a...Read more

China approves Phase II clinical trial of InnoCare's cancer drug

Drug Discovery |  News | 0 Comment | 03 Mar, 2022

InnoCare Pharma, a leading biopharmaceutical company, has announced the Investigational New Drug (IND) approval of its B...Read more

China-based Fosun Pharma and Insilico Medicine advance AI-driven drug discovery

Drug Discovery |  News | 0 Comment | 12 Jan, 2022

Shanghai Fosun Pharmaceutical (Group) Co. and Insilico Medicine have entered into a collaboration agreement to advance t...Read more

Taiwan's GoldenBiotech suggests 100% recovery with oral drug Antroquinonol in COVID-19 patients

Drug Discovery |  News | 0 Comment | 10 Jan, 2022

Golden Biotechnology Corp., a leading Taiwanese biopharmaceutical company, has announced that its Phase 2 COVID-19 trial...Read more

Korean startup Astrogen to use AI for drug design against Parkinson’s Disease

Drug Discovery |  News | 1 Comment | 06 Jan, 2022

South Korea-based startup Astrogen and Paris-based firm Iktos have announced a research collaboration to use A...Read more

Japan's PRISM BioLab partners with Roche and Genentech for drug discovery research

Drug Discovery |  News | 0 Comment | 05 Jan, 2022

PRISM BioLab, a Japan based biotechnology company with a proprietary peptide mimetic small molecule drug discovery ...Read more

China’s BeiGene expands collaboration with Novartis for oncology medicines

Drug Discovery |  News | 0 Comment | 28 Dec, 2021

China-based BeiGene has announced an option, collaboration and license agreement with Novartis Pharma AG to develop, man...Read more